EMV 1.91% $2.57 emvision medical devices ltd

Ann: Australian Stoke Alliance Successful in Frontiers Bid, page-3

  1. 4,189 Posts.
    lightbulb Created with Sketch. 1077
    The highly competitive MRFF Frontiers program provides funding aimed at developing the next big medical breakthrough. In Stage 1, just ten groups have been selected to receive funding of up to $1 million each over 12 months to develop detailed plans for their research programs and make Stage 2 submissions.

    Stage 2 is anticipated to support the best applicants from Stage 1 and depending upon the project, Stage 2 grants are pledged at $50 million or more per group and can extend over five years. The Company is working closely with the Australian Stroke Alliance to develop the research plan for a competitive Stage 2 program bid. The Company expects to collaborate on a Stage 2 application within the next 12 months.

    It is expected that EMvision will provide in kind contributions during Stage 1, principally through the provision of expertise and guidance from existing employees and benefit from similar contributions made by other Australian Stroke Alliance program collaborators. The Company’s involvement is subject to entering into a collaboration agreement with The Melbourne Brain Centre and other Australian Stroke Alliance project collaborators.


    RMFDO
    Last edited by stotes: 22/05/19
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
(20min delay)
Last
$2.57
Change
-0.050(1.91%)
Mkt cap ! $219.5M
Open High Low Value Volume
$2.62 $2.65 $2.54 $67.61K 26.18K

Buyers (Bids)

No. Vol. Price($)
1 299 $2.57
 

Sellers (Offers)

Price($) Vol. No.
$2.60 2241 2
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
$2.56
  Change
-0.050 ( 3.17 %)
Open High Low Volume
$2.57 $2.65 $2.55 6310
Last updated 15.59pm 28/03/2024 ?
EMV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.